About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

tDCS for Laryngeal Dystonia | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNANCT06830174

tDCS for Laryngeal Dystonia

This project will apply transcranial direct current stimulation (tDCS) to multiple brain areas to evaluate the effects as a potential treatment for laryngeal dystonia (formerly spasmodic dysphonia).

Lead sponsor: Yale University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Nabin Koirala, PhD

CONTACT

203 7852527 [email protected]

Sponsors

Lead Sponsor

Yale University

Collaborators

National Spasmodic Dysphonia Association

Baseline neuroimaging data will be acquired from all participants via MRI, EEG. Each participant will be seen for multiple testing sessions over a five day period. LD participants will undergo the neuromodulation (HD-tDCS Stimulation) for twenty minutes while engaged in watching videos/movies or performing a word production task.

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Participants must be clinically evaluated for the diagnosis of LD or have the proof of LD diagnosis. (Not applicable for control participants)
•No other known or history of speech, voice disorder other than LD.
•Provision of signed and dated informed consent form.
•Stated willingness to comply with all study procedures and availability for the duration of the study
•Must not be pregnant.

Exclusion Criteria

•All individuals who do not meet the above mentioned criteria are excluded from the study.
•Subjects with a history of epilepsy or depression or is claustrophobic.

Related studies

Brain-Computer Interfaces in Laryngeal Dystonia

NCT04421365 · Laryngeal Dystonia

Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor

NCT05150106 · Laryngeal Dystonia, Spasmodic Dysphonia, and more

COMPLETEDPhase 1/2

Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia

NCT06111027 · Spasmodic Dysphonia, Laryngeal Dystonia

Cortical Silent Period in Laryngeal Dystonia

NCT05580302 · Laryngeal Dystonia, Spasmodic Dysphonia

Reversal of Botulinum Neurotoxin Injection Related Dysphonia With Pyridostigmine

NCT05110417 · Dysphonia, Spastic, Dysphonia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 9, 2026Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment10

Start dateApr 2025

Last updatedFeb 9, 2026

Condition

Laryngeal Dystonia

Locations shown

Yale University

New Haven, Connecticut

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 9, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions